These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 26985016)

  • 21. Can estrogens promote hypertension during systemic lupus erythematosus?
    Venegas-Pont M; Ryan MJ
    Steroids; 2010 Nov; 75(11):766-71. PubMed ID: 20178809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of regulatory T cells using low-dose interleukin-2 attenuates hypertension in an experimental model of systemic lupus erythematosus.
    Taylor EB; Sasser JM; Maeda KJ; Ryan MJ
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1274-F1284. PubMed ID: 30892934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress promotes hypertension and albuminuria during the autoimmune disease systemic lupus erythematosus.
    Mathis KW; Venegas-Pont M; Masterson CW; Stewart NJ; Wasson KL; Ryan MJ
    Hypertension; 2012 Mar; 59(3):673-9. PubMed ID: 22291449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus.
    Aringer M; Smolen JS
    Arthritis Res Ther; 2003; 5(4):172-7. PubMed ID: 12823847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
    Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
    Front Immunol; 2020; 11():1047. PubMed ID: 32625200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High dietary fat promotes visceral obesity and impaired endothelial function in female mice with systemic lupus erythematosus.
    Gilbert EL; Ryan MJ
    Gend Med; 2011 Apr; 8(2):150-5. PubMed ID: 21536233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus.
    Rahman ZS; Tin SK; Buenaventura PN; Ho CH; Yap EP; Yong RY; Koh DR
    J Immunol; 2002 Mar; 168(6):3042-9. PubMed ID: 11884477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin attenuates autoimmunity and renal injury in an experimental model of systemic lupus erythematosus.
    Dent EL; Taylor EB; Turbeville HR; Ryan MJ
    Physiol Rep; 2020 Jul; 8(13):e14501. PubMed ID: 32652896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation.
    Lourenço EV; Liu A; Matarese G; La Cava A
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10637-42. PubMed ID: 27588900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic lupus erythematosus and hypertension.
    Munguia-Realpozo P; Mendoza-Pinto C; Sierra Benito C; Escarcega RO; Garcia-Carrasco M; Mendez Martinez S; Etchegaray Morales I; Galvez Romero JL; Ruiz-Arguelles A; Cervera R
    Autoimmun Rev; 2019 Oct; 18(10):102371. PubMed ID: 31415907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
    Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
    Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic Lupus Erythematosus and Cardiovascular Disease.
    Jha SB; Rivera AP; Flores Monar GV; Islam H; Puttagunta SM; Islam R; Kundu S; Sange I
    Cureus; 2022 Feb; 14(2):e22027. PubMed ID: 35282557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic agonists reduce blood pressure in a mouse model of systemic lupus erythematosus.
    Fairley AS; Mathis KW
    Physiol Rep; 2017 Apr; 5(7):. PubMed ID: 28400502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood pressure in a hypertensive mouse model of SLE is not salt-sensitive.
    Mathis KW; Venegas-Pont M; Masterson CW; Wasson KL; Ryan MJ
    Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1281-5. PubMed ID: 21917908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An impaired neuroimmune pathway promotes the development of hypertension in systemic lupus erythematosus.
    Mathis KW
    Am J Physiol Regul Integr Comp Physiol; 2015 Nov; 309(9):R1074-7. PubMed ID: 26084696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosus.
    Rivera-Gonzalez O; Case CT; Wilson NA; Speed JS; Taylor EB
    Am J Physiol Endocrinol Metab; 2023 Jan; 324(1):E73-E84. PubMed ID: 36476039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
    Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
    Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sodium 4-phenylbutyrate treatment protects against renal injury in NZBWF1 mice.
    Bonnemaison ML; Marks-Nelson ES; Boesen EI
    Clin Sci (Lond); 2019 Jan; 133(2):167-180. PubMed ID: 30617186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.